Why the Biomedical 'Crisis' Really Isn't
The nation's biomedical research enterprise is in a serious crisis, says a new report from America's top universities. Because of shortfalls in funding from the National Institutes of Health (NIH), only 20% of the projects submitted for funding are being supported. Researchers are spending more time writing grants than doing science. Brilliant young investigators are leaving science in frustration. And the historic U.S. lead in biotech is threatened, said Dr. Edward Miller, chief executive officer of Johns Hopkins Medicine and dean of the university's School of Medicine, at a Mar. 19 Senate briefing on the new report. "It is a disaster," he says.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.
- Uber Paid Hackers to Delete Stolen Data on 57 Million People
- Tesla’s Burning Through Nearly Half a Million Dollars Every Hour
- New Uber CEO Keeps Finding Horrors at Every Turn
- Facebook to Show Users Which Russian Propaganda They Followed
- Jamie Dimon Says He'd Bet Donald Trump Doesn't Win Again in 2020